Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 23,897	$ 26,756
General and administrative	6,974	6,566
Total operating expenses	30,871	33,322
Loss from operations	(30,871)	(33,322)
Interest income	2,918	2,666
Interest expense	(2)	(19)
Other expense, net	(61)	(206)
Loss before income tax provision	(28,016)	(30,881)
Income tax provision	0	0
Net loss	$ (28,016)	$ (30,881)
Net loss per share attributable to common stockholders, basic	$ (0.35)	$ (0.72)
Net loss per share attributable to common stockholders, diluted	$ (0.35)	$ (0.72)
Weighted-average common shares used in computing net income (loss) per share attributable to common stockholders, basic	79,071,652	42,955,688
Weighted-average common shares used in computing net income (loss) per share attributable to common stockholders, diluted	79,071,652	42,955,688